Post-filing evidence is generally allowable to support deficiencies in a patent application, such as those related to lack of enablement or inventive step, or in a granted patent, for example, when the patent is undergoing an invalidation action. However, not every jurisdiction treats this practice similarly. This webinar will provide an overview of practice in Canada, the United States, and Europe.
Christopher Bezak is a partner in the Washington, D.C. office of Sughrue Mion, in the Electrical and Internet E-Commerce & Software Practice Groups, with industry background in Information Technology and Computer/Telecommunications networks. Mr. Bezak’s practice areas cover complex subject matters including Artificial Intelligence (AI), Internet technologies, and Standard Essential Patents (SEPs) in telecommunications (3G/4G/etc.) and audio/video encoding. And Mr. Bezak’s practice areas include patent opinion, counseling, and due diligence, and patent application drafting and patent prosecution before the U.S. Patent and Trademark Office, including before the Patent Trial and Appeal Board (PTAB) in ex parte appeals and Inter Partes Review (IPR) post-grant challenges, as well as in U.S. District Courts.
Danièle Ethier is a registered patent agent and a partner at ROBIC, a Canadian based intellectual property law firm. Danièle specializes in intellectual property with a focus on patent procurement and opinions in the life sciences sector. She has extensive experience in protecting innovations relating to pharmaceuticals and biologicals. Prior to joining ROBIC, she held the position of Director, Intellectual Property at Virochem Pharma. Danièle also held a similar position, in the global intellectual property group of Shire Pharmaceuticals, where she was responsible for managing an important patent portfolio in a variety of core areas including antiviral and vaccine technologies. Danièle graduated from Université de Montréal with a Bachelor in Biochemistry (B. Sc.).
Richard Gibbs has over 15 years of experience in the IP profession; in that time he has gathered an extensive portfolio across all types of client – from large multinational companies to universities, SMEs and start-ups and individuals. With experience of all forms of IP, Richard advises in the field of biotechnology and has particular expertise in technologies relating to genetic testing (pre-natal diagnosis), antibodies, stem cells, vaccines, biologics, virology, bacteriology, diagnostics and molecular biology. He has worked with all of Scotland’s major universities and is a regular speaker at IP conferences and events.
Richard joined the patent profession after a period as both a research scientist and a university lecturer having obtained an honours degree in medical microbiology and a doctorate in immunology and microbiology from the University of Edinburgh. Richard is now the Managing Partner of the firm's Glasgow office and has a lead role in the management of the firm’s life science group. In recognition of his achievements, Richard is mentioned by Managing Intellectual Property’s IP Stars as “recommended for life sciences patent work”.
Full refunds will be issued only if a cancellation is received in writing by Wednesday, August 28, 2019: Cancellations received after that date will be subject to a service charge of $75.00 USD. No refunds will be issued for program cancellations requested after 12:00 Noon EST on Wednesday, September 11, 2019. Send cancellation notices by e-mail to email@example.com.
For hotel reservations, please contact the Embassy Suites by Hilton: All reservations must be made individually through the hotel's Reservation Department online through this link or by calling 1-800-EMBASSY and using the reference group code ALY. *You must mention the AIPF 2019 Annual Meeting to receive the discounted rate of $239.00 USD for single or double occupancy per night (excluding taxes). This rate is available until the room block is sold-out or until 5:00pm on August 30, 2019.
Association of Intellectual Property Firms (AIPF)
c/o RRR Associations, LLC2125 Center Ave., Suite 406, Fort Lee, NJ, USA 07024
T: 1.201.308.6948 F: 1.201.461.6635 E: firstname.lastname@example.org